Identification of compounds that rescue otic and myelination defects in the zebrafish adgrg6 (gpr126) mutant.
Elvira DiamantopoulouSarah BaxendaleAntonio de la Vega de LeónAnzar AsadCelia J HoldsworthLeila AbbasValerie J GilletGiselle R WigginTanya T WhitfieldPublished in: eLife (2019)
Adgrg6 (Gpr126) is an adhesion class G protein-coupled receptor with a conserved role in myelination of the peripheral nervous system. In the zebrafish, mutation of adgrg6 also results in defects in the inner ear: otic tissue fails to down-regulate versican gene expression and morphogenesis is disrupted. We have designed a whole-animal screen that tests for rescue of both up- and down-regulated gene expression in mutant embryos, together with analysis of weak and strong alleles. From a screen of 3120 structurally diverse compounds, we have identified 68 that reduce versican b expression in the adgrg6 mutant ear, 41 of which also restore myelin basic protein gene expression in Schwann cells of mutant embryos. Nineteen compounds unable to rescue a strong adgrg6 allele provide candidates for molecules that may interact directly with the Adgrg6 receptor. Our pipeline provides a powerful approach for identifying compounds that modulate GPCR activity, with potential impact for future drug design.
Keyphrases
- gene expression
- dna methylation
- wild type
- high throughput
- binding protein
- transcription factor
- induced apoptosis
- poor prognosis
- fatty acid
- escherichia coli
- oxidative stress
- current status
- small molecule
- emergency department
- white matter
- pseudomonas aeruginosa
- signaling pathway
- climate change
- long non coding rna
- cystic fibrosis
- cell proliferation
- biofilm formation
- human health
- protein protein
- amino acid
- staphylococcus aureus
- peripheral nerve
- single cell